nanoparticle albumin-bound paclitaxel; Nab-paclitaxel (Abraxane)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

  • injectable

Adverse effects

Mechanism of action

More general terms

References

  1. FDA News Release: Sept. 6, 2013 FDA approves Abraxane for late-stage pancreatic cancer. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm367442.htm
  2. Abraxane prescribing information http://www.abraxane.com/downloads/Abraxane_PrescribingInformation.pdf
  3. 3.0 3.1 Von Hoff DD et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24131140 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1304369